By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > NSAID > Naproxen

Naproxen

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|631 words

Naproxen Drug Profile

What is Naproxen?

Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) commonly used to reduce pain, inflammation, and fever. It belongs to the propionic acid class of NSAIDs and is available both over-the-counter and by prescription in various strengths. Naproxen works by blocking enzymes that produce inflammatory substances in the body, making it effective for treating conditions ranging from headaches to arthritis.

Uses

Naproxen is approved for several pain and inflammatory conditions:

  • Arthritis: Reduces joint pain and stiffness associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis
  • Acute pain: Treats moderate pain from injuries, dental procedures, or minor surgeries
  • Menstrual cramps: Alleviates pain and discomfort associated with primary dysmenorrhea
  • Headaches and migraines: Provides relief from tension headaches and some types of migraines
  • Fever reduction: Lowers elevated body temperature in adults and children over 12 years
  • Tendinitis and bursitis: Reduces inflammation and pain in affected tendons and joints

How it works

Naproxen works by inhibiting cyclooxygenase (COX) enzymes, specifically COX-1 and COX-2, which are responsible for producing prostaglandins. Prostaglandins are chemical messengers that promote inflammation, pain, and fever in the body. By blocking these enzymes, naproxen reduces the production of prostaglandins, thereby decreasing inflammation, relieving pain, and lowering fever.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Stomach upset or nausea
  • Heartburn or indigestion
  • Dizziness or headache
  • Drowsiness or fatigue
  • Constipation or diarrhea
  • Gas or bloating
  • Ringing in the ears
  • Fluid retention or swelling

Serious side effects requiring immediate medical attention:

  • Stomach bleeding or ulcers (black, tarry stools or vomiting blood)
  • Heart attack or stroke symptoms (chest pain, shortness of breath, weakness on one side)
  • Severe allergic reactions (difficulty breathing, swelling of face or throat)
  • Liver problems (yellowing of skin or eyes, dark urine)
  • Kidney problems (changes in urination, swelling of legs or feet)

Warnings and precautions

  • Cardiovascular risk: May increase risk of heart attack and stroke, especially with long-term use or in people with existing heart conditions
  • Gastrointestinal bleeding: Can cause stomach ulcers and bleeding, particularly in elderly patients or those with a history of ulcers
  • Pregnancy considerations: Should be avoided during the third trimester as it may cause harm to the unborn baby and complicate delivery
  • Kidney and liver function: Use with caution in patients with impaired kidney or liver function, as naproxen is processed by these organs
  • Elderly patients: Higher risk of serious side effects, particularly gastrointestinal and cardiovascular complications

Interactions

  • Blood thinners (warfarin): Increases bleeding risk when combined with naproxen
  • ACE inhibitors and ARBs: May reduce effectiveness of these blood pressure medications and increase kidney damage risk
  • Diuretics: Naproxen can reduce the effectiveness of water pills and worsen kidney function
  • Lithium: Naproxen can increase lithium levels in the blood, leading to toxicity
  • Methotrexate: Increases risk of methotrexate toxicity by reducing its elimination from the body
  • Other NSAIDs: Taking multiple NSAIDs together increases risk of side effects without added benefit
  • Corticosteroids: Combined use increases risk of gastrointestinal bleeding and ulcers
  • Alcohol: Increases risk of stomach bleeding and liver damage

Check interactions with the GMJ Interaction Checker

Dosage

Adult dosing varies based on the condition being treated and formulation used. For over-the-counter use, the typical dose is 220 mg every 8-12 hours, not exceeding 660 mg in 24 hours. Prescription strengths may range from 250 mg to 500 mg taken twice daily, with maximum daily doses typically not exceeding 1,500 mg. For arthritis, doses are usually higher and taken regularly, while for acute pain, lower doses may be used as needed. Always start with the lowest effective dose for the shortest duration necessary. Dosage should always be determined by a healthcare provider based on individual medical conditions, age, and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Naproxen." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/naproxen/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
First-Trimester NSAIDs and Birth Defects: Large Cohort Study Finds No Increased Risk
In the news
  • First-Trimester NSAIDs and Birth Defects: Large Cohort Study Finds No Increased Risk · May 19, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How a single stem cell in bone marrow generates your entire immune system

All blood and immune cells originate from a single pluripotent hematopoietic stem…

How amino acids shape brain function: neurotransmitters, energy, and cognitive resilience

Amino acids are the precursors to neurotransmitters and metabolic substrates for brain…

How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Mefenamic acid

By
Prof. Giorgi Pkhakadze
02/06/2026

Celecoxib

By
Prof. Giorgi Pkhakadze
02/06/2026

Ketorolac

By
Prof. Giorgi Pkhakadze
02/06/2026

Indomethacin

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up